Joseph C. Papa
2021 - Valeant Pharmaceuticals International
Compensation breakdown
| Non-Equity Incentive Plan | $2,448,000 |
|---|---|
| Option Awards | $2,250,054 |
| Salary | $1,600,000 |
| Stock Awards | $16,561,105 |
| Other | $29,978 |
| Total | $22,889,137 |
Papa received $16.6M in stock awards, accounting for 72% of the total pay in 2021.
Papa also received $2.4M in non-equity incentive plan, $2.3M in option awards, $1.6M in salary and $30K in other compensation.
Rankings
In 2021, Joseph C. Papa's compensation ranked 255th out of 12,397 executives tracked by ExecPay. In other words, Papa earned more than 97.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 255 out of 12,397 | 98th |
Division Manufacturing | 73 out of 5,492 | 99th |
Major group Chemicals And Allied Products | 24 out of 2,367 | 99th |
Industry group Drugs | 20 out of 2,090 | 99th |
Industry Pharmaceutical Preparations | 10 out of 1,537 | 99th |
Pay ratio
| Joseph C. Papa's Pay | $22,889,137 |
|---|---|
| Median Employee's Pay | $44,617 |
| Pay Ratio | 513to 1 |
In 2021, the annual total compensation of Joseph C. Papa was $22,889,137.
The annual total compensation of the median employee at Valeant Pharmaceuticals International was $44,617.
The ratio of Joseph C. Papa's pay to the pay of median employee was therefore 513 to one.
Papa's colleagues
We found five more compensation records of executives who worked with Joseph C. Papa at Valeant Pharmaceuticals International in 2021.
2021
Thomas Appio
Valeant Pharmaceuticals International
President Co, Head Bausch + Lomb/International
2021
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
2021
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
2021
Sam Eldessouky
Valeant Pharmaceuticals International
Chief Financial Officer
2021
Robert Spurr
Valeant Pharmaceuticals International